SEC23IP

SEC23-interacting protein · Q9Y6Y8 · SEC23IP on Sugi Atlas →

0 patent compounds predicted against SEC23IP, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SEC23IP by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Valproate and Levocarnitine in Children With Spinal Muscular Atrophy PHASE3UNKNOWN
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers PHASE1/PHASE2RECRUITING
Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients PHASE1UNKNOWN
Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid Tumors PHASE1WITHDRAWN
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Evaluation of CEMIP in Pancreatic Cancer nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Lymphoid Tyrosine Phosphatase Gene Polymorphisms in Inflammatory Bowel Disease nanUNKNOWN
Association Between Intakes of Protein, Calcium and Milk With Gene Expression and Linear Growth of School Aged Children nanCOMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
The Influence of Genetic Variations in ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation in Humans nanUNKNOWN
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas nanACTIVE_NOT_RECRUITING
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases nanNOT_YET_RECRUITING
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
Investigation of Biomarkers in Susac Syndrome nanUNKNOWN
Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia nanRECRUITING
Autophagy Bladder Cancer nanUNKNOWN
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia nanRECRUITING
Genetic Studies of Inflammatory Bowel Disease nanCOMPLETED
Biomarkers in Idiopathic Juvenile Arthritis nanUNKNOWN
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. nanUNKNOWN
Immunohistochemical Expression of EGFR in the Patients Having Oral Squamous Cell Carcinoma nanCOMPLETED
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Integrins and Protocadherins in Glutamatergic Circuits: Identification of Common Signaling Pathways and Molecular Targets in Anxiety and Major Depressive Disorders (GAPsy) nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SEC23IP binder may also engage these)

ProteinNameSimilarity
Q6NZC7 1.000 Q6NZC7 →
Q8W5R2 0.996 Q8W5R2 →
G5EEM9 0.996 G5EEM9 →
Q27974 0.995 Q27974 →
DDHD2 Triacylglycerol hydrolase DDHD2 0.995 landscape →
Q32NW2 0.994 Q32NW2 →
SMARCC2 SWI/SNF complex subunit SMARCC2 0.994 landscape →
P43125 0.994 P43125 →
Q8CHU3 0.993 Q8CHU3 →
Q92539 0.993 Q92539 →
P97496 0.993 P97496 →
B3M301 0.993 B3M301 →
Q6P158 0.993 Q6P158 →
SMARCC1 SWI/SNF complex subunit SMARCC1 0.993 landscape →
Q6E3D4 0.993 Q6E3D4 →
Q8VYB5 0.993 Q8VYB5 →
O75061 0.993 O75061 →
O43078 0.993 O43078 →
DHX29 ATP-dependent RNA helicase DHX29 0.992 landscape →
Q7SIG6 0.992 Q7SIG6 →
B4NBP4 0.992 B4NBP4 →
P53990 0.992 P53990 →
Q8K0V4 0.992 Q8K0V4 →
A3KMI0 0.992 A3KMI0 →
O43150 0.992 O43150 →
Q9Z2Q1 0.992 Q9Z2Q1 →
Q6PGC1 0.992 Q6PGC1 →
Q92562 0.992 Q92562 →
O43166 0.992 O43166 →
G5EDY0 0.992 G5EDY0 →